Search results
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Cipla is a leading pharmaceutical company that provides affordable medicine to patients across geographies. Over the last 8 decades, we have been fortifying our promise of ‘Caring for Life'.
Championing Care. Nourishing Careers. Search jobs. LIFE AT CIPLA. Our incredible global workforce is the backbone of our success! Their unwavering commitment to excellence has played a critical role in our journey.
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.
20 hours ago · Cipla plans to start supplying from its China facility to the US market by the second half of the current fiscal year, following USFDA approval. The company is resolving regulatory issues with its domestic plants and focusing on new therapeutic areas and tech-based solutions. Cipla is also addressing antimicrobial resistance and expanding its digital health initiatives.
2 days ago · Cipla's shares jumped 6.7 per cent to a record high of 1,600 rupees after the results. Sales in North America grew 13 per cent during the quarter, primarily driven by Cipla's respiratory drug ...
3 days ago · Cipla Limited Stock Price Today, Live NSE Share Price: Get the latest Cipla Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
3 days ago · Cipla Ltd reported on 26 July that its Q1 FY25 net profit rose 18.3 percent on-year to Rs 1,178 crore, beating analyst estimates. The drugmaker's April-June revenue from operations rose 7 percent ...
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the...
2 days ago · Cipla's revenue rose by 7% to Rs 6,694 crore, and net profit increased by 18% to Rs 1,178 crore for quarter 1 FY25, owing to strong India and US businesses. CEO Umang Vohra noted growth in India's ...
